LVT — Levitee Labs Share Price
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -173.2% | ||
| Return on Equity | -133.53% | ||
| Operating Margin | -192.39% | ||
Financial Summary
| Year End 30th Sep | Unit | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E | 2023E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | n/a | n/a | n/a | n/a | 1.72 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Levitee Labs Inc. is a Canada-based integrative wellness company. The Company focuses on the centralization of integrative wellness assets. It is involved in transforming the traditional landscape of mental health, addiction, and pain management treatments through evidence-based complementary medicines and psychedelic therapies through its portfolio of wellness assets. The Company’s portfolio of assets includes Levitee Clinics, Levitee Pharmacies, Levitee Nutraceuticals and Sporeo. Levitee Clinics is a group of five operating addiction and pain treatment clinics in Alberta. Levitee Pharmacies includes three pharmacies operating in Alberta specialized in filling prescriptions for patients with substance use disorders, mental health conditions, and chronic pain. Levitee Nutraceuticals includes MONKE Nutra, Ojio, Earth Shift and Earth Circle Organics. Sporeo products are available through retail, wholesale, and ecommerce channels and defragments the mushroom cultivation ecosystem.
Directors
- Last Annual
- September 30th, 2021
- Last Interim
- June 30th, 2022
- Incorporated
- January 23rd, 2019
- Public Since
- July 21st, 2021
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
- Canadian Securities Exchange
- Shares in Issue
- 75,823,886
- Address
- 215-800 West Pender St, VANCOUVER, V6C 1J8
- Web
- https://www.leviteelabs.com/
- Phone
- Auditors
- RSM Alberta LLP
Similar to LVT
Adaptogenics Health
Canadian Securities Exchange
Affinor Growers
Canadian Securities Exchange
Aretto Wellness
Canadian Securities Exchange
AREV Life Sciences Global
Canadian Securities Exchange
Ayurcann Holdings
Canadian Securities Exchange
FAQ
As of Today at 09:48 UTC, shares in Levitee Labs are trading at CA$0.01. This share price information is delayed by 15 minutes.
Shares in Levitee Labs last closed at CA$0.01 and the price had moved by -96.55% over the past 365 days. In terms of relative price strength the Levitee Labs share price has underperformed the Toronto Stock Exchange 300 Composite Index by -96.89% over the past year.
The overall consensus recommendation for Levitee Labs is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Levitee Labs does not currently pay a dividend.
Levitee Labs does not currently pay a dividend.
Levitee Labs does not currently pay a dividend.
To buy shares in Levitee Labs you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of CA$0.01, shares in Levitee Labs had a market capitalisation of .
Here are the trading details for Levitee Labs:
- Country of listing: Canada
- Exchange: CNX
- Ticker Symbol: LVT
Based on an overall assessment of its quality, value and momentum Levitee Labs is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Levitee Labs. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -75.63%.
As of the last closing price of CA$0.01, shares in Levitee Labs were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Levitee Labs PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.01.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Levitee Labs' directors